CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice. - Wikidata - wikimedia - TriplyDB

CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.

CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.

http://www.wikidata.org/entity/Q37402372

about

T-Cell Therapy: Options for Infectious Diseases Coevolution of T-cell receptors with MHC and non-MHC ligands Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials Role of Group 1 CD1-Restricted T Cells in Infectious Disease CD1 and mycobacterial lipids activate human T cells Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them The CD1 size problem: lipid antigens, ligands, and scaffolds A conserved human T cell population targets mycobacterial antigens presented by CD1b Diverse antigen presentation by the Group 1 CD1 molecule, CD1c.Mammalian CD1 and MR1 genes The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.Lipid antigens in immunity.Natural killer T cell recognition of lipid antigens.Lysosomal-associated transmembrane protein 5 (LAPTM5) is a molecular partner of CD1e.Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection Bee venom processes human skin lipids for presentation by CD1a Autoreactive CD1b-restricted T cells: a new innate-like T-cell population that contributes to immunity against infection Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.Targeting iNKT cells for the treatment of sickle cell disease.Nonclassical MHC Ib-restricted CD8+ T Cells Recognize Mycobacterium tuberculosis-Derived Protein Antigens and Contribute to Protection Against Infection Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model Immunologic mapping of glycomes: implications for cancer diagnosis and therapy It is time to beelieve the CD1a hype!CD1b-autoreactive T cells recognize phospholipid antigens and contribute to antitumor immunity against a CD1b+ T cell lymphoma.Targeting Innate-Like T Cells in Tuberculosis.Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.Cellular response to mycobacteria: balancing protection and pathology.Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?Activation of human T cells by CD1 and self-lipids.Group 1 CD1-restricted T cells and the pathophysiological implications of self-lipid antigen recognition.Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.The role of MHC class Ib-restricted T cells during infection.Donor-unrestricted T cells in the human CD1 system.Mechanisms and Consequences of Antigen Presentation by CD1.Natural killer T cells in atherosclerosis.The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers.

P2860

Q26786661-1789BEC4-299A-493D-860A-27FB1B99C89F Q26797242-DA34346B-B3D8-4BCD-BDBF-F67F9297E2A8 Q26797333-744B8DB7-EC73-47CF-96FF-D04F3AF79F07 Q26801636-878526EE-4880-41F3-AF83-8CCA180E6F51 Q26863207-508E258F-A3C8-4095-A9FF-FA87A638574B Q26996562-A28D130E-77F1-470F-B019-F2F79BE16611 Q27024188-929B6C4D-53BD-4B38-BEED-59BB1CFE7BB0 Q27678457-059CE219-C2CC-41D5-8E42-E58C1C241CAA Q27693283-9B2FA0D1-BC3D-48BE-9980-05D3ACC9DAB5 Q28596919-DA7D2E69-EB92-4690-9F7E-21337D55C0DF Q33658959-133465DC-90A1-4C97-91E0-6CA6E31147FD Q33699588-E43A0355-0384-4F76-B28A-B9549BF0EFD0 Q33796925-3F5CF5F4-3836-4C6D-ACD6-1C6E3A89708B Q34025822-F1EBC6D9-16B6-4199-929D-E76E17D93932 Q34167301-3677E5CE-71D8-410B-B43E-98E0A20BD397 Q34374461-BB30AD5E-E41D-469C-AB0E-9DEF24BD837B Q34983782-DF82FFCF-A854-444B-87C0-F4A79E0449BA Q35015787-BADAD8D1-3573-4381-9B43-87FEE7A31F40 Q35064888-FDD47BB5-3EF5-47D2-9907-D0582C2E028C Q35346349-C4BF6DD5-0E90-45FC-A7D6-4DA46661D46B Q35589680-DC9DADF4-EE9D-46C9-AEB5-1D1AA1736EFD Q35845442-8F23A7C7-A6F1-45C3-9D6A-125CC9913776 Q35893688-DD197E1E-3E8E-41C6-9141-22A3080C3BED Q36043783-1512CEDB-5A14-4729-BD48-1514EECB4531 Q36479685-0F71BFE8-4913-4FCD-9898-E456200C6944 Q36543504-FFE37293-9B09-4E88-B0EA-8888393EE5A1 Q36592678-EDFF32B7-784E-46FF-ADFF-16395FB20967 Q37308220-65D52D3A-181C-4FFC-B12A-86816F77450E Q37522519-121D666B-20D2-4489-B624-F3019068D8B7 Q37599845-06211E41-88D1-4CAC-B1FE-D0EEBCEB348B Q37826931-5CD5B4F1-8DB1-4A70-BF3F-F1850424FB85 Q38063960-43CECE6A-68ED-41BC-81BE-9F68AB7C608B Q38568857-1448C7B8-F3CC-44F7-84BF-CAE183333B5A Q38619546-A22CC4C3-5282-42EF-88DE-A4C552DA60B9 Q38735507-E2DE4E42-BC2D-485A-8271-EA1F60E7B9A5 Q38883507-E2609336-C9AA-4E9F-9074-F426F0A7BF09 Q38922079-CD24E3ED-4BE0-4773-9272-3001475DEEF5 Q38953250-742DC618-2169-4FF0-B59F-5E0BC5520EB1 Q39105646-912D4D8F-011C-4D6E-847D-246B9E4F1A9E Q39344161-BD8688A1-87C0-4230-A6F4-00EAA6305FBA

P2860

CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.

http://www.wikidata.org/entity/Q37402372

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD1-restricted adaptive immune ...... n group 1 CD1 transgenic mice.

@en

CD1-restricted adaptive immune ...... n group 1 CD1 transgenic mice.

@nl

type

label

CD1-restricted adaptive immune ...... n group 1 CD1 transgenic mice.

@en

CD1-restricted adaptive immune ...... n group 1 CD1 transgenic mice.

@nl

prefLabel

CD1-restricted adaptive immune ...... n group 1 CD1 transgenic mice.

@en

CD1-restricted adaptive immune ...... n group 1 CD1 transgenic mice.

@nl

P1433

Q37402372-CE4C6D3E-5B6E-49AE-82C4-BC2CC85FA566

P1476

Q37402372-D199BD5B-9DC2-4311-8BD9-8B9166C86E0A

P2093

Q37402372-0570976B-71EE-4ADA-8CD1-D6BAE22F8E3C

Q37402372-2771BBCC-0964-48D6-A70B-27A571CF8A68

Q37402372-6FC2374D-F35F-4EB7-9B1D-7A0A5D6EDB5C

Q37402372-9BBA45B4-CAF2-4B3A-9CD2-89185D759CB3

Q37402372-B0CAA6B0-7601-40FC-A90B-9A80F5702D86

Q37402372-BABBE399-0542-4E71-AA85-77E6F268590D

Q37402372-C755B9FC-84A7-447C-9227-56F5F2C81924

Q37402372-D4F2FF46-3CA7-41C8-B9B8-B78AE10B6AF9

Q37402372-E8F19542-2591-45F0-B7D5-7BDA32AC4B79

P2860

Q37402372-0319128C-CE13-4DD7-8E19-653B87331B7B

Q37402372-0DA3A186-EAF6-4A94-9D24-6ED899F59A2C

Q37402372-10588E36-C527-4DF4-A7C3-4B2132B375B0

Q37402372-110C4B4A-D6F0-48D4-99F1-9C983AA52862

Q37402372-150D2BED-49B7-42F5-8115-01FFCDC7C0AC

Q37402372-27D7E5DA-942F-460B-A84A-F7CB67F6EB7B

Q37402372-2F221445-4618-478F-B8B7-0FF819982E7C

Q37402372-2F592671-2221-4BA9-B916-4679FD227378

Q37402372-3336530E-CFE3-4BF7-97C8-4EEFA28170C5

Q37402372-33434E04-5DF4-464A-B0BB-E68433B289C6

P304

Q37402372-297F9C73-6C37-4CBF-8BAD-D2705D9D0B0D

P31

Q37402372-D4F4851C-641E-4DDF-BF13-CBC3688F1CBA

P356

Q37402372-0427C4BE-B948-4A85-877A-3C95277459C6

P407

Q37402372-EF97494A-0358-4F36-BBC0-11EA5FCD13F0

P433

Q37402372-F544DCA4-44A7-4C37-A237-393744E24682

P478

Q37402372-BA560D5F-D038-47C8-9B45-44555FB541F7

P50

Q37402372-89C6DA3D-D27C-4E8C-B8F5-75B5317BC40F

P577

Q37402372-B0B345FB-3899-43CD-BFCB-2C518C6BBA8E

P5875

Q37402372-232630C5-9058-4D78-BC67-C45C1DC93346

P698

Q37402372-913F91AC-F1B8-4FD4-9754-FFCDC00229C9

P932

Q37402372-637D9388-209C-4A4C-919C-0823AB4D5DA8

P356

P1433

Journal of Experimental Medicine

P1476

CD1-restricted adaptive immune ...... n group 1 CD1 transgenic mice.

@en

P2093

Angela Colmone

http://www.w3.org/2001/XMLSchema#string

Christopher C Dascher

http://www.w3.org/2001/XMLSchema#string

Chyung-Ru Wang

http://www.w3.org/2001/XMLSchema#string

Hak-Jong Choi

http://www.w3.org/2001/XMLSchema#string

Hanh Nguyen

http://www.w3.org/2001/XMLSchema#string

Kyrie Felio

http://www.w3.org/2001/XMLSchema#string

Michael B Brenner

http://www.w3.org/2001/XMLSchema#string

Michael I Zimmer

http://www.w3.org/2001/XMLSchema#string

Sha Li

http://www.w3.org/2001/XMLSchema#string

P2860

Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture

Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

CD1: antigen presentation and T cell function

The biology of NKT cells

CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection

CD1-restricted T cell recognition of microbial lipoglycan antigens

Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice.

Conservation of a CD1 multigene family in the guinea pig.

Glycolipid antigen induces long-term natural killer T cell anergy in mice.

P304

2497-2509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20090898

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P50

David Branch Moody

P577

2009-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26875252

http://www.w3.org/2001/XMLSchema#string

P698

19808251

http://www.w3.org/2001/XMLSchema#string

P932

2768849

http://www.w3.org/2001/XMLSchema#string